SEC Form 4 · accession 0001209191-15-083986
Minerva Neurosciences, Inc. · NERV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frederick W Ahlholm
Officer — SVP, Chief Accounting Officer
Period of report
Dec 4, 2015
Accepted (ET)
Dec 8, 2015 · 4:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001598646
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $4.71 | Dec 4, 2015 | A | 69,000 | A | — | Dec 3, 2025 | Common Stock | 69,000 | 69,000 | D |
Explanation of responses
- F1The exercise price is the closing price of the Issuer's common stock on December 4, 2015.
- F2This option shall vest as follows: 25% on December 4, 2016; and then in quarterly installments over 3 years thereafter.